Actively Recruiting
Validation of Flavin Mononucleotide FMN as a Marker for Liver Graft Viability During Normothermic Machine Perfusion Using OrganOx Metra
Led by The Cleveland Clinic · Updated on 2026-06-04
850
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying liver transplant patients to evaluate the use of Flavin Mononucleotide FMN levels measured in perfusate and bile during normothermic machine perfusion NMP as markers of graft viability. This multicenter observational study involves donors after circulatory death DCD or brain death DBD and aims to validate FMN as a predictor of graft function and complications up to one year after transplant. The study is led by the Cleveland Clinic and includes multiple sites in the US and UK. During the study, discarded perfusate samples will be collected from donor organs while on the OrganOx metra device for normothermic machine perfusion prior to transplantation. FMN levels will be measured as part of standard care for all machine perfusion liver transplant cases. The transplant procedure will then continue as usual following sample collection. Samples from outside sites will be collected following strict shipping and preservation guidelines but will be discarded after analysis. Participants will undergo liver transplantation with back-to-base NMP using the OrganOx metra device. Researchers will monitor graft functionality by measuring FMN levels in perfusate and bile and correlate these with post-transplant outcomes such as graft loss, biliary complications, vascular issues, rejection episodes, and other related complications for up to one year. Data on interventions needed and severity of complications will also be collected. The study includes both retrospective and prospective patient enrollment with follow-up assessments to validate FMN as a clinical viability marker.
CONDITIONS
Brief Title
Viability Assessment Using FMN Measured in Perfusate and Bile During Normothermic Machine Perfusion
Research Team
M
Mary Bilancini, MS
E
Erlind Allkushi, BS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here